Catalyst Repository | Evoke Pharma Inc. Common Stock

Evoke Pharma Inc. Common Stock

(NASDAQ:EVOK)

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

EVOK Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$3.0500
Previous Close Volume
23750